NEUPOGEN
NEUPOGEN
Approved
DIN Number
01968017
Drug Class
Human
Market Date
Dec 31, 1992
Company
HC
Amgen Canada Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number01968017
AIG Number0123525001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
L03AA02 FILGRASTIM
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
,
Subcutaneous
AHFS Classification20:16.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
FILGRASTIMActive
Strength: 300 MCG / ML
Monograph: FILGRASTIM